{
 "as_of": "2026-11-06",
 "cmr": "jp-cm-kg/TSE-GROWTH/4883",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# Modalis Therapeutics Corporation (Growth Market: 4883) — research page\n\nAs of 2026-11-06 · jp-cm-kg · record version 1\n\n## Identity and listing\n\nModalis Therapeutics Corporation is listed on the Growth Market under ticker 4883. The record does not carry an ISIN or an LEI for the issuer. The security type is Corporate, the sector is 3250 Pharmaceutical, and the jurisdiction is Japan (EDINET domestic filer). The segment is not on the record. The listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 7 filings in the twelve months to 2026-11-06, across 4 filing days. The median gap between filing days is 61 days. The latest filing is dated 2026-08-14, 84 days before the record date, and is of type regulatory_filing. The Growth Market median cadence gap is 42 days across 598 issuers, and the median latency is 85.0 days. The 3250 Pharmaceutical sector median cadence gap is 49.5 days across 80 issuers, and the median latency is 85.0 days. The issuer's cadence gap is above the Growth Market median and above the sector median. The issuer's latency is below both medians.\n\n## Auditor\n\nThe auditor of record is アルファ監査法人. Its location is not on the record. The record does not carry auditor changes for this issuer.\n\n## Events and halts\n\nThe record does not carry listing, delisting, name change, domicile change or segment move events for this issuer, because no lifecycle type map exists for this register. The issuer is listed and not halted.\n\n## Orderability\n\nThe rule version is acm-68000/jp/suitability-principle-fiea-article-40/r1, with a chapter as of 2026-11-04. For Qualified Institutional Investors the outcome is not determinable. The rule states a product scope, the subject's class carries no CFI to place on the scope bridge, and no scope object names the class, so the subject is not shown within the scope.\n\n## Coverage\n\nNo research houses were found on the issuer's investor-relations page. The count is 0.\n\n## Open research\n\nNo openly published research notes were found. The count is 0.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe vintage for this market is not sealed. No issuer years are sealed, and the market's earliest sealed date and the live record start date are not on the record.\n\n## Sources\n\n7 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx (identity.exchange)\n- https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip (identity.jurisdiction)\n- https://mcp.jp-cm-kg.ai/events/TSE-GROWTH/4883 (the disclosure lines)\n- https://www.jpx.co.jp/markets/equities/suspended/index.html (the halt flag)\n- https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XSHO (the auditor)\n- https://mcp.jp-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://mcp.jp-cm-kg.ai/record/TSE-GROWTH/4883 (the record)\n",
 "market": "JP",
 "node": "jp-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": null,
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "the JP vintage is not sealed; the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false
  },
  "auditor": {
   "auditor": {
    "read_by": "EDINET XBRL-to-CSV facts (API v2 type=5, 有価証券報告書 docTypeCode 120) — element jpcrp_cor:AuditFirm1Consolidated",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XSHO",
    "state": "sourced",
    "value": "アルファ監査法人"
   },
   "auditor_firm_id": {
    "market": "JP",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "JP",
    "state": "not_on_record"
   },
   "changes": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "jp-cm-kg/TSE-GROWTH/4883",
  "coverage": {
   "count": 0,
   "houses": [],
   "pages_checked": [],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": null,
   "state": "none_found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 598,
     "median_cadence_gap_days": 42,
     "median_filings": 8,
     "median_latency_days": 85,
     "name": "Growth Market"
    },
    "sector": {
     "issuers": 80,
     "median_cadence_gap_days": 49.5,
     "median_filings": 8,
     "median_latency_days": 85,
     "name": "3250 Pharmaceutical"
    }
   },
   "by_type": {
    "ad_hoc": 1,
    "prospectus": 1,
    "regulatory_filing": 3,
    "results": 2
   },
   "cadence_median_gap_days": 61,
   "filing_days": 4,
   "filings": 7,
   "latency_days": 84,
   "latest": [
    {
     "category": "135",
     "date": "2026-08-14",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YWX5",
     "title": "確認書",
     "type": "regulatory_filing"
    },
    {
     "category": "半期報告書 (half-year report)",
     "date": "2026-08-14",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YVRI",
     "title": "半期報告書－第11期(2026/01/01－2026/12/31)",
     "type": "results"
    },
    {
     "category": "有価証券届出書 (securities registration statement)",
     "date": "2026-05-27",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100Y6SQ",
     "title": "有価証券届出書（組込方式）",
     "type": "prospectus"
    },
    {
     "category": "臨時報告書 (extraordinary report)",
     "date": "2026-03-27",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XUXP",
     "title": "臨時報告書",
     "type": "ad_hoc"
    },
    {
     "category": "235",
     "date": "2026-03-25",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XSHR",
     "title": "内部統制報告書－第10期(2025/01/01－2025/12/31)",
     "type": "regulatory_filing"
    }
   ],
   "latest_filing_date": "2026-08-14",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.jp-cm-kg.ai/events/TSE-GROWTH/4883",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "Growth Market"
   },
   "isin": {
    "market": "JP",
    "reason": "no LEI, so no GLEIF ISIN route",
    "state": "not_on_record"
   },
   "jurisdiction": {
    "read_by": "EDINET code list (Edinetcode.zip, filer master with corporate number) (提出者種別)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip",
    "state": "sourced",
    "value": "Japan (EDINET domestic filer)"
   },
   "lei": {
    "market": "JP",
    "reason": "no GLEIF record registered as 0100-01-172984 (RA000412)",
    "state": "not_on_record"
   },
   "name": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "Modalis Therapeutics Corporation"
   },
   "sector": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English) (33-sector classification)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "3250 Pharmaceutical"
   },
   "security_type": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "JP",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "4883"
   },
   "website": {
    "market": "JP",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "JP",
  "node": "jp-cm-kg",
  "numbers_hash": "sha256:6b6d54b12953e4ec1888a8ed9102e29cf9e167dd430922b377ffa9dea4dd622d",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [
    "Qualified Institutional Investors"
   ],
   "outcomes": {
    "Qualified Institutional Investors": {
     "determinable": false,
     "reason": "the rule states a product scope; the subject's class carries no CFI to place on the scope bridge, and no scope object names the class: the subject is not shown within the scope",
     "signal": null
    }
   },
   "read": {
    "basis": "one live read per instrument class, halt state and client category on this market; this issuer's group",
    "chapter": "https://mcp.jp-cm-kg.ai/book/aio.json",
    "door": "https://mcp.jp-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "rule_version": "acm-68000/jp/suitability-principle-fiea-article-40/r1",
   "section": "jp.aio.v6"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.jp-cm-kg.ai/record/TSE-GROWTH/4883",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-08",
   "source": "https://www.jpx.co.jp/markets/equities/suspended/index.html",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:6b6d54b12953e4ec1888a8ed9102e29cf9e167dd430922b377ffa9dea4dd622d",
 "path": "/jp/TSE-GROWTH/4883",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "Modalis Therapeutics Corporation is listed on the Growth Market under ticker 4883. The record does not carry an ISIN or an LEI for the issuer. The security type is Corporate, the sector is 3250 Pharmaceutical, and the jurisdiction is Japan (EDINET domestic filer). The segment is not on the record. The listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 7 filings in the twelve months to 2026-11-06, across 4 filing days. The median gap between filing days is 61 days. The latest filing is dated 2026-08-14, 84 days before the record date, and is of type regulatory_filing. The Growth Market median cadence gap is 42 days across 598 issuers, and the median latency is 85.0 days. The 3250 Pharmaceutical sector median cadence gap is 49.5 days across 80 issuers, and the median latency is 85.0 days. The issuer's cadence gap is above the Growth Market median and above the sector median. The issuer's latency is below both medians.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is アルファ監査法人. Its location is not on the record. The record does not carry auditor changes for this issuer.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The record does not carry listing, delisting, name change, domicile change or segment move events for this issuer, because no lifecycle type map exists for this register. The issuer is listed and not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The rule version is acm-68000/jp/suitability-principle-fiea-article-40/r1, with a chapter as of 2026-11-04. For Qualified Institutional Investors the outcome is not determinable. The rule states a product scope, the subject's class carries no CFI to place on the scope bridge, and no scope object names the class, so the subject is not shown within the scope.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "No research houses were found on the issuer's investor-relations page. The count is 0.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found. The count is 0.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The vintage for this market is not sealed. No issuer years are sealed, and the market's earliest sealed date and the live record start date are not on the record.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "7 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.jp-cm-kg.ai/events/TSE-GROWTH/4883"
  },
  {
   "for": "the halt flag",
   "source": "https://www.jpx.co.jp/markets/equities/suspended/index.html"
  },
  {
   "for": "the auditor",
   "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XSHO"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.jp-cm-kg.ai/book/aio.json"
  },
  {
   "for": "the record",
   "source": "https://mcp.jp-cm-kg.ai/record/TSE-GROWTH/4883"
  }
 ],
 "title": "Modalis Therapeutics Corporation (4883) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}